For some patients with moderate to high nearsightedness, laser vision correction is not always the best fit. EVO ICL offers another option by placing a corrective lens inside the eye without removing the eye’s natural lens or reshaping the cornea. The procedure can reduce dependence on glasses or contact lenses while preserving the natural corneal structure. EVO ICL is FDA-approved for myopia, and the toric version can also correct myopic astigmatism.
Steven B. Siepser, M.D., F.A.C.S., has decades of experience with refractive surgery, intraocular lenses, and complex vision correction cases at Siepser Eyecare in Wayne, PA. His background is especially valuable for patients with high prescriptions, thin corneas, or other eye characteristics that may complicate treatment planning. A detailed evaluation can help determine whether EVO ICL or another vision correction option better fits the individual eye.
What Is EVO ICL?
EVO ICL is an implantable collamer lens that is placed inside the eye to correct nearsightedness. Unlike refractive lens exchange, the natural lens remains in place. The implanted lens sits behind the iris and in front of the natural crystalline lens, where it helps bend incoming light so it focuses more accurately on the retina.
The toric version of EVO ICL is designed for patients who have both nearsightedness and astigmatism. Because the cornea itself is not reshaped, EVO ICL can offer an alternative for some patients who may not be ideal candidates for LASIK or PRK.
Who May Be a Candidate for EVO ICL?
EVO ICL is not appropriate for every patient, so candidacy depends on a detailed eye examination.
Factors that may be considered include:
- Degree of nearsightedness
- Presence of astigmatism
- Prescription stability
- Corneal thickness and shape
- Depth of the anterior chamber
- Overall eye health
- Age and visual goals
Current FDA labeling allows EVO ICL treatment for eligible adults ages 21 through 60, with additional requirements related to prescription range, eye anatomy, and prescription stability.
How Is EVO ICL Different From LASIK or PRK?
LASIK and PRK correct refractive errors by reshaping the cornea with a laser. EVO ICL takes a different approach by adding a corrective lens inside the eye while leaving the corneal tissue largely unchanged.
That distinction can make EVO ICL especially worth considering for patients with higher levels of nearsightedness or corneal characteristics that make laser treatment less suitable.
Another important difference is that EVO ICL does not remove the natural lens. This separates it from refractive lens exchange, where the natural lens is replaced with an artificial intraocular lens.
What Happens During EVO ICL Surgery?
During the procedure, the surgeon inserts the lens through a small opening in the eye and positions it behind the iris, where it is generally not visible afterward. The natural lens remains intact.
Patients typically receive numbing medication to keep the eye comfortable during treatment. After surgery, prescription eye drops and follow-up visits support healing and allow monitoring of lens position, eye pressure, and vision.
Visual improvement can occur relatively quickly, although recovery varies by individual.
What Are the Benefits and Considerations of EVO ICL?
One of the main advantages of EVO ICL is that it can correct substantial nearsightedness without removing corneal tissue. The lens can also be surgically removed if necessary, although the procedure should still be viewed as a significant eye surgery rather than a temporary treatment.
As with any intraocular procedure, risks and trade-offs exist. These can include changes in eye pressure, cataract formation, inflammation, infection, glare, halos, and other complications. A comprehensive evaluation helps weigh these considerations against the potential visual benefits.
Why Choose Siepser Eyecare for EVO ICL?
Choosing an implantable lens procedure requires careful attention to both refractive needs and the eye’s internal anatomy. Steven B. Siepser, M.D., F.A.C.S., has extensive experience in refractive correction, cataract surgery, intraocular lens conditions, and managing implant-related complications. He is also known throughout the Philadelphia region for taking on difficult cases that may require more individualized surgical planning.
That combination of refractive and lens-based expertise can be especially valuable for patients considering EVO ICL because candidacy depends on more than prescription strength alone. Siepser Eyecare can also address dry eye, ocular disease, and other factors that may influence visual quality before or after treatment, helping create a more complete plan for long-term eye health.
Explore EVO ICL in Wayne, PA
EVO ICL may provide an effective alternative for patients with nearsightedness who are looking beyond glasses, contacts, LASIK, or PRK. A comprehensive evaluation can determine whether the procedure fits your prescription, eye anatomy, and vision goals. Call Siepser Eyecare in Wayne, PA, at (610) 265-2020 to schedule a consultation and learn whether EVO ICL may be right for you.